Literature DB >> 22364152

Clinicopathological study of invasive extramammary Paget's disease: subgroup comparison according to invasion depth.

T Shiomi1, T Noguchi, H Nakayama, Y Yoshida, O Yamamoto, N Hayashi, K Ohara.   

Abstract

BACKGROUND: Extramammary Paget's disease (EMPD) is a distinct form of malignant skin neoplasm. Invasive EMPD is relatively rare and its detailed histopathological features have not been investigated to date.
METHODS: Surgical specimens were obtained from 51 patients with primary invasive EMPD. Clinical data including lymph node status were retrieved from the patients' medical records. Cases were divided into subgroups according to invasion depth: dermal invasion ≤ 1 mm (minimal invasion) and dermal invasion > 1 mm in depth. Histological patterns (nodular/glandular pattern or micronodular pattern), lymphatic/venous invasion, mitosis and lymph node status were compared between the two groups.
RESULTS: The invasive EMPDs included 26 cases (51.0%) with dermal invasion ≤ 1 mm (minimal invasion) and 25 cases (49.0%) with dermal invasion > 1 mm in depth. Lymph node metastasis was detected in 2/26 (7.7%) patients with minimally invasive EMPD. Nodular/glandular pattern (72.0%), lymphatic/venous invasion (52.0%), mitosis (88.0%) and nodal metastasis (88.0%) were all significantly more frequent in cases with dermal invasion > 1 mm, compared to EMPDs with dermal invasion ≤ 1 mm (minimal invasion) (P < 0.001).
CONCLUSION: These results suggest that invasive EMPD can be divided according to invasion depth, with a cut-off depth of 1 mm. This might represent the basis for a useful, EMPD-specific staging system.
© 2012 The Authors. Journal of the European Academy of Dermatology and Venereology © 2012 European Academy of Dermatology and Venereology.

Entities:  

Mesh:

Year:  2012        PMID: 22364152     DOI: 10.1111/j.1468-3083.2012.04489.x

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN: 0926-9959            Impact factor:   6.166


  10 in total

1.  The Possible Interaction between Receptor Activator of Nuclear Factor Kappa-B Ligand Expressed by Extramammary Paget Cells and its Ligand on Dermal Macrophages.

Authors:  Yumi Kambayashi; Taku Fujimura; Sadanori Furudate; Masayuki Asano; Aya Kakizaki; Setsuya Aiba
Journal:  J Invest Dermatol       Date:  2015-05-27       Impact factor: 8.551

2.  Magnetic resonance imaging for extramammary Paget's disease: radiological and pathological correlations.

Authors:  Gensuke Akaike; Taiki Nozaki; Masaki Matsusako; Mizuko Matsui; Naoyuki Ohtake; Hikaru Eto; Koyu Suzuki; Yukihisa Saida
Journal:  Skeletal Radiol       Date:  2012-11-15       Impact factor: 2.199

Review 3.  Surgical Treatment for Extramammary Paget's Disease.

Authors:  Uwe Wollina; Alberto Goldman; Andrzej Bieneck; Mohamed Badawy Abdel-Naser; Sven Petersen
Journal:  Curr Treat Options Oncol       Date:  2018-05-03

Review 4.  Current Management and Treatment of Extramammary Paget's Disease.

Authors:  Hiroki Hashimoto; Takamichi Ito
Journal:  Curr Treat Options Oncol       Date:  2022-04-04

5.  Tumor Wide Horizontal Invasion Predicts Local Recurrence for Scrotal Extramammary Paget's Disease.

Authors:  Lujia Wang; Chenchen Feng; Minwei Zhou; Zhongwen Zhou; Guanxiong Ding; Peng Gao; Qiang Ding; Zhong Wu
Journal:  Sci Rep       Date:  2017-03-21       Impact factor: 4.379

Review 6.  Metastatic Extramammary Paget's Disease: Pathogenesis and Novel Therapeutic Approach.

Authors:  Keitaro Fukuda; Takeru Funakoshi
Journal:  Front Oncol       Date:  2018-02-16       Impact factor: 6.244

7.  Mucosal Invasion, but Not Incomplete Excision, Has Negative Impact on Long-Term Survival in Patients With Extramammary Paget's Disease.

Authors:  Hiroki Hashimoto; Yumiko Kaku-Ito; Masutaka Furue; Takamichi Ito
Journal:  Front Oncol       Date:  2021-04-15       Impact factor: 6.244

8.  Potential use of bisphosphonates in invasive extramammary Paget's disease: an immunohistochemical Investigation.

Authors:  Taku Fujimura; Sadanori Furudate; Yumi Kambayashi; Setsuya Aiba
Journal:  Clin Dev Immunol       Date:  2013-03-31

9.  Chemokine Receptors CXCR4 and CXCR7 are Associated with Tumor Aggressiveness and Prognosis in Extramammary Paget Disease.

Authors:  Kun Chang; Gao-Xiang Li; Yun-Yi Kong; Xu-Xia Shen; Yuan-Yuan Qu; Zhong-Wei Jia; Yue Wang; Bo Dai; Ding-Wei Ye
Journal:  J Cancer       Date:  2017-08-02       Impact factor: 4.207

10.  Extramammary Paget's disease.

Authors:  Andres Vasquez; Cristina Dominguez; Mariam Rolon
Journal:  BJR Case Rep       Date:  2016-05-25
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.